Stocklytics Platform
Asset logo for symbol PRTG
Portage Biotech
PRTG54
$7.94arrow_drop_down3.75%-$0.30
Penny Stock
Asset logo for symbol PRTG
PRTG54

$7.94

arrow_drop_down3.75%
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.89%
Last Dividend pay dateJun 4, 2020
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

PRTG-
US Healthcare Sector-
US Market-
warning

PRTG / Market

PRTG lose to the US Market which returned 0.03% over the last twenty four hours.
warning

PRTG / Healthcare Sector

PRTG lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

Portage Biotech (PRTG) Statistics

The stock statistics of Portage Biotech Inc., PRTG provide valuable insights into the performance of the company's stock in the market. These statistics include various measures such as the stock's price, trading volume, market capitalization, and price-to-earnings ratio. By analyzing these metrics, investors can assess the current and historical performance of the stock. This information helps them make informed decisions about buying or selling PRTG shares. Additionally, stock statistics can be used to compare PRTG's performance with other companies in the same sector, providing a broader perspective on the company's stock performance.
Valuation metrics are important for investors to evaluate the attractiveness of Portage Biotech Inc., PRTG stock. These metrics include the stock's price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio. By comparing these metrics with industry benchmarks, investors can determine whether the stock is overvalued or undervalued. Fundamental analysis is crucial for understanding the financial health of Portage Biotech Inc., PRTG. Fundamental metrics such as revenue, net income, and operating cash flow provide insights into the company's growth potential and profitability. Evaluating these metrics helps investors make sound investment decisions.
add Portage Biotech to watchlist

Keep an eye on Portage Biotech

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Portage Biotech (PRTG) stock's performance compared to its sector and the market over the past year?

Over the past year, Portage Biotech (PRTG) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Portage Biotech has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Portage Biotech's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Portage Biotech (PRTG) stock?

The PE ratio for Portage Biotech (PRTG) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Portage Biotech (PRTG) stock?

The Earnings Per Share (EPS) for Portage Biotech (PRTG), calculated on a diluted basis, is -$68.17. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Portage Biotech (PRTG) stock?

The operating margin for Portage Biotech (PRTG) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Portage Biotech (PRTG) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Portage Biotech (PRTG) is -$11.72M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Portage Biotech (PRTG) have?

Portage Biotech (PRTG) has a total debt of $28K. The net debt, which accounts for cash and cash equivalents against the total debt, is -$1.74M.

Take Your Investments to a Whole New Level